The most frequently reported issues for new patients were nausea, constipation, and GI issues
PlexusDx goes deeper by offering the Precision Peptide Genetic Test, an add-on available after your first month of treatment
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the treatment of type 2 diabetes mellitus and, more recently, obesity
The relationship between GLP-1 receptor agonists and generalized skin sensitivity remains unclear, as there is no official established link between these medications and widespread sensitive skin as a direct pharmacological effect
Yet beneath that success lies a fragile architecture built on convenience, marketing, and data liquidity
Rare cases of allergic skin reactions have been reported with GLP-1 use, including urticaria (hives), rash, and pruritus (itching)